Slope and LabConnect reported significant progress in their partnership since introducing their API integration last year, with multiple shared customers going live in December 2025 and additional studies set to launch in early 2026, further extending an integrated central lab and site technology approach that improves biospecimen lifecycle operations.
The Slope + LabConnect partnership extends LabConnect’s technology ecosystem through API Integration enabling electronic data exchange between Slope’s site-facing platform and LabConnect’s LIMS. Together, the systems connect site, sponsor, and laboratory workflows for lab kit and bulk supply ordering, inventory visibility, sample shipment, and the transfer of key sample and subject metadata using Slope’s site-validated, lab-agnostic technology.
“Over the past year, we’ve moved from announcing the API to demonstrating real-world impact for sponsors launching trials via the Slope + LabConnect integration,” said Jim Munz, Chief Product and Technology Officer at Slope. “The clinical trials span diverse therapeutic areas and demonstrate that seamless integration between sample management solutions and central labs can improve efficiency across clinical operations.”
“This partnership strengthens LabConnect’s ability to deliver biospecimen excellence through our broader, more connected technology ecosystem,” said Charles Castano, Chief Technology Officer at LabConnect. “Slope provides site-level inventory and sample management that integrates into our existing laboratory and data infrastructure without requiring new hardware. The integration also gives us access to Slope’s network of 2,200+ sites already utilizing the platform, which has driven a 98% site adoption rate on sponsor-contracted trials.”
Through the API integration, manual and automated lab kit resupply orders generated within LabConnect flow directly into Slope, giving sponsors enhanced visibility and control over site inventory management. Study teams can set customizable thresholds at the site and protocol level, establish order approval workflows, and monitor inventory status through Slope’s centralized reports and dashboards.
Inventory shipments from LabConnect to sites are fully digitized, enabling sites and sponsors to view inbound supply manifests and track package-level delivery status in real time. Once deliveries arrive on site, inventory counts update automatically within the platform. As patient visits occur, samples are registered, or inventory expires, counts adjust in real time, eliminating the need for sites to manually report expired kits and reducing delays between collection and laboratory receipt. Proactive alerts notify teams when inventory runs low or approaches expiration, helping prevent shortages before they occur.
On the sample side, the integration enables sites to eliminate their reliance on lab manuals in favor of Slope’s guided workflows for sample collection, processing, storage, and shipment. These workflows support the electronic capture and transfer of subject, visit, and sample metadata — streamlining sample registration and data updates in LabConnect’s LIMS. This eliminates the dependency on paper requisition forms, enabling LabConnect to pre-accession samples, and allows discrepancies to be identified before shipments arrive, reducing queries and downstream delays.
The joint solution is also powering more advanced operational models. For trials requiring home health services, Slope + LabConnect now enable supply tracking across multiple shipping addresses per site — critical for studies using mobile nurses or satellite hubs, while simplifying multi-location inventory management for large academic centers and decentralized trial models.
Looking ahead, the companies are extending the integration to support additional sample-tracking workflows, including enhancing lab-to-lab transfers. These capabilities are planned for release beginning in early 2026, further strengthening sponsors’ ability to manage biospecimen operations holistically through connected laboratory and site technologies.
Learn more about how this API integration is streamlining clinical trial operations and improving data exchange across the biospecimen lifecycle, at the website here.
Related News:
LabConnect Establishes New Global Raleigh NC Headquarters
LabConnect and OmniScience Unveil Vivo AI for Clinical Trial Insights
